by Omar Figueroa and Lauren Mendelsohn May 16, 2024 On May 16, 2024, the Biden Administration announced that the United States Department of Justice is taking the next step in the reclassification of cannabis from a Schedule I controlled substance to a Schedule III controlled substance — which would […]
Read More
By Lauren Mendelsohn December 22, 2023 Today, United States President Joseph Biden issued an official proclamation granting a pardon to Americans who have been convicted of, charged with, attempted to, or did use or possess marijuana for personal use in violation of U.S. federal law or Washington, D.C. city […]
Read More
by Omar Figueroa and Lauren Mendelsohn August 30, 2023 The U.S. Department of Health and Human Services (HHS) is suggesting that cannabis should be reclassified from Schedule I to Schedule III under federal law. This significant shift reflects the view that cannabis no longer has a high potential for abuse […]
Read More
by Omar Figueroa December 21, 2022 The Drug Enforcement Administration (DEA) has confirmed that any seed, tissue culture, or other genetic material is not controlled under the Controlled Substances Act (CSA) as long as it has less than 0.3% of delta-9-THC. Specifically, on December 20, 2022, the DEA […]
Read More
December 6, 2019 By Andrew Kingsdale On December 3, 2019, federal banking agencies released a joint statement clarifying requirements under the Bank Secrecy Act (BSA) for banks providing financial services to hemp growers. Because hemp is no longer a Schedule I controlled substance under the Controlled Substances Act, banks are […]
Read More
January 4, 2018 – Today, United States Attorney General Jefferson B. Sessions, III rescinded a number of federal memoranda that provided guidance regarding marijuana and medical marijuana enforcement. Included in the memos that were rescinded is the Cole Memo, which laid out eight marijuana enforcement priorities for federal prosecutors in […]
Read More